Albemarle Corporation (ALB) is up 7.7% today. Here is some analysis on what might have caused this price movement.
Analysis: Albemarle shares appear to be rising with the broader lithium complex after a sharp move higher in China lithium carbonate futures, which tends to lift sentiment across lithium producers. The move also likely reflects renewed expectations for tighter supply/demand conditions in 2026, improving the market’s view of Albemarle’s earnings power and cash generation through the cycle.
Details:
Sources:
TradingView (Reuters), Albemarle (Investor Presentation)
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$ALB Insider Trading Activity
$ALB insiders have traded $ALB stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $ALB stock by insiders over the last 6 months:
- J KENT MASTERS (Chairman & CEO) has made 0 purchases and 3 sales selling 11,783 shares for an estimated $2,012,687.
- ERIC NORRIS (Chief Commercial Officer) sold 5,692 shares for an estimated $941,741
- ANDER C. KRUPA (General Counsel & Sec) has made 0 purchases and 2 sales selling 288 shares for an estimated $29,080.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ALB Hedge Fund Activity
We have seen 466 institutional investors add shares of $ALB stock to their portfolio, and 446 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 4,150,223 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $336,500,080
- FRANKLIN RESOURCES INC removed 2,712,135 shares (-82.1%) from their portfolio in Q4 2025, for an estimated $383,604,374
- TORONTO DOMINION BANK added 1,645,889 shares (+6959.4%) to their portfolio in Q4 2025, for an estimated $232,794,540
- CASTLE HOOK PARTNERS LP added 1,463,199 shares (+inf%) to their portfolio in Q4 2025, for an estimated $206,954,866
- UBS GROUP AG removed 1,142,190 shares (-54.1%) from their portfolio in Q4 2025, for an estimated $161,551,353
- INVESCO LTD. removed 998,544 shares (-36.2%) from their portfolio in Q4 2025, for an estimated $141,234,063
- PHOENIX FINANCIAL LTD. added 919,426 shares (+inf%) to their portfolio in Q4 2025, for an estimated $130,043,613
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ALB Analyst Ratings
Wall Street analysts have issued reports on $ALB in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 01/28/2026
- UBS issued a "Buy" rating on 01/12/2026
- Baird issued a "Outperform" rating on 01/07/2026
- BMO Capital issued a "Outperform" rating on 11/19/2025
- RBC Capital issued a "Outperform" rating on 11/10/2025
- Rothschild & Co issued a "Buy" rating on 10/24/2025
To track analyst ratings and price targets for $ALB, check out Quiver Quantitative's $ALB forecast page.
$ALB Price Targets
Multiple analysts have issued price targets for $ALB recently. We have seen 17 analysts offer price targets for $ALB in the last 6 months, with a median target of $190.0.
Here are some recent targets:
- Stephen Richardson from Evercore ISI Group set a target price of $180.0 on 02/18/2026
- Rock Hoffman from B of A Securities set a target price of $190.0 on 02/17/2026
- Arun Viswanathan from RBC Capital set a target price of $216.0 on 02/17/2026
- Patrick Cunningham from Citigroup set a target price of $190.0 on 02/13/2026
- John Roberts from Mizuho set a target price of $185.0 on 02/12/2026
- Jeffrey Zekauskas from JP Morgan set a target price of $195.0 on 01/28/2026
- Laurence Alexander from Jefferies set a target price of $230.0 on 01/28/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.